TREA

97315301 - S

Follow

Information

  • Trademark
  • 97315301
  • Serial Number
    97315301
  • Filing Date
    March 16, 2022
    2 years ago
  • Transaction Date
    July 12, 2024
    6 months ago
  • Status Date
    June 17, 2024
    6 months ago
  • Published for Opposition Date
    March 21, 2023
    a year ago
  • Location Date
    May 16, 2023
    a year ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    FITZSIMONS, MICHAEL R
  • Attorney Docket Number
    V03132000900
    Attorney Name
    Christina M. Licursi
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
3
Mark Identification
S
Case File Statements
  • DM0000: The mark consists of a stylized "S".
  • GS0051: Therapeutic products in the nature of pharmaceuticals to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism; pharmaceutical agents that modulate metabolism for scientific and research use
  • PM0001: SENDA
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0421: Research and development in the field of computational biology, biotechnology and pharmaceuticals
Case File Event Statements
  • 1/9/2023 - 2 years ago
    5 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/22/2022 - 2 years ago
    1 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/27/2022 - 2 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/9/2023 - 2 years ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/9/2023 - 2 years ago
    4 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/19/2023 - a year ago
    6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/19/2023 - a year ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/19/2023 - a year ago
    8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/16/2023 - a year ago
    9 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/16/2023 - a year ago
    10 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/16/2023 - a year ago
    11 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/16/2023 - a year ago
    12 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/16/2023 - a year ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/1/2023 - a year ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/21/2023 - a year ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/16/2023 - a year ago
    17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/21/2023 - a year ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/10/2023 - a year ago
    18 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/10/2023 - a year ago
    19 - SOU EXTENSION 1 FILED Type: EXT1
  • 11/10/2023 - a year ago
    20 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 6/17/2024 - 6 months ago
    22 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/12/2024 - 6 months ago
    23 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 11/14/2023 - a year ago
    21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA